Status:
COMPLETED
High Sensitivity Troponin T Levels Following DC Cardioversion for Atrial Fibrillation / Atrial Flutter
Lead Sponsor:
University of Limerick
Conditions:
Atrial Fibrillation
Atrial Flutter
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine if there is a rise in serum high sensitivity troponin T (a marker for heart muscle injury) following a direct current cardioversion (shock therapy) used for p...
Detailed Description
High sensitivity Troponin T is a relatively new biomarker that is highly sensitive and specific for myocardial injury. Its widespread use has helped in the determination and investigation for myocardi...
Eligibility Criteria
Inclusion
- Patients with atrial fibrillation / atrial flutter attending for direct current external cardioversion
- Age 18 or older
Exclusion
- Myocardial infarction within the last 6 weeks
- Coronary artery bypass grafting, percutaneous coronary intervention or any other invasive cardiac procedure within the last 6 weeks
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT02268799
Start Date
October 1 2014
End Date
August 1 2015
Last Update
August 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Limerick
Dooradoyle, Limerick, Ireland